BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31121321)

  • 1. V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function.
    Demirev AV; Song HL; Cho MH; Cho K; Peak JJ; Yoo HJ; Kim DH; Yoon SY
    Neurobiol Dis; 2019 Sep; 129():182-194. PubMed ID: 31121321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease.
    Nackenoff AG; Hohman TJ; Neuner SM; Akers CS; Weitzel NC; Shostak A; Ferguson SM; Mobley B; Bennett DA; Schneider JA; Jefferson AL; Kaczorowski CC; Schrag MS
    PLoS Genet; 2021 Apr; 17(4):e1009406. PubMed ID: 33830999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.
    Zhang DF; Fan Y; Wang D; Bi R; Zhang C; Fang Y; Yao YG
    Mol Neurobiol; 2016 Aug; 53(6):4034-4045. PubMed ID: 26189833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLD3 in Alzheimer's disease.
    Wang J; Yu JT; Tan L
    Mol Neurobiol; 2015 Apr; 51(2):480-6. PubMed ID: 24935720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
    Cruchaga C; Karch CM; Jin SC; Benitez BA; Cai Y; Guerreiro R; Harari O; Norton J; Budde J; Bertelsen S; Jeng AT; Cooper B; Skorupa T; Carrell D; Levitch D; Hsu S; Choi J; Ryten M; Sassi C; Bras J; Gibbs RJ; Hernandez DG; Lupton MK; Powell J; Forabosco P; Ridge PG; Corcoran CD; Tschanz JT; Norton MC; Munger RG; Schmutz C; Leary M; Demirci FY; Bamne MN; Wang X; Lopez OL; Ganguli M; Medway C; Turton J; Lord J; Braae A; Barber I; Brown K; ; Pastor P; Lorenzo-Betancor O; Brkanac Z; Scott E; Topol E; Morgan K; Rogaeva E; Singleton A; Hardy J; Kamboh MI; George-Hyslop PS; Cairns N; Morris JC; Kauwe JSK; Goate AM
    Nature; 2014 Jan; 505(7484):550-554. PubMed ID: 24336208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.
    Blanco-Luquin I; Altuna M; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Cámara M; Zelaya V; Erro ME; Echavarri C; Mendioroz M
    Clin Epigenetics; 2018 Sep; 10(1):116. PubMed ID: 30208929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.
    Tan MS; Zhu JX; Cao XP; Yu JT; Tan L
    J Alzheimers Dis; 2018; 64(1):55-59. PubMed ID: 29865074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
    Wang C; Tan L; Wang HF; Yu WJ; Liu Y; Jiang T; Tan MS; Hao XK; Zhang DQ; Yu JT;
    J Alzheimers Dis; 2015; 46(2):491-5. PubMed ID: 26402410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rare variants in TREM2 and PLD3 on longitudinal cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Engelman CD; Darst BF; Bilgel M; Vasiljevic E; Koscik RL; Jedynak BM; Johnson SC
    Neurobiol Aging; 2018 Jun; 66():177.e1-177.e5. PubMed ID: 29395285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.
    Satoh J; Kino Y; Yamamoto Y; Kawana N; Ishida T; Saito Y; Arima K
    Alzheimers Res Ther; 2014; 6(9):70. PubMed ID: 25478031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.
    Cacace R; Van den Bossche T; Engelborghs S; Geerts N; Laureys A; Dillen L; Graff C; Thonberg H; Chiang HH; Pastor P; Ortega-Cubero S; Pastor MA; Diehl-Schmid J; Alexopoulos P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Sanchez-Valle R; Lladó A; Gelpi E; Almeida MR; Santana I; Tsolaki M; Koutroumani M; Clarimon J; Lleó A; Fortea J; de Mendonça A; Martins M; Borroni B; Padovani A; Matej R; Rohan Z; Vandenbulcke M; Vandenberghe R; De Deyn PP; Cras P; van der Zee J; Sleegers K; Van Broeckhoven C;
    Hum Mutat; 2015 Dec; 36(12):1226-35. PubMed ID: 26411346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China.
    Jiao B; Liu X; Tang B; Hou L; Zhou L; Zhang F; Zhou Y; Guo J; Yan X; Shen L
    Neurobiol Aging; 2014 Oct; 35(10):2422.e9-2422.e11. PubMed ID: 24866402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification and characterization of the 5' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay.
    Cappel C; Gonzalez AC; Damme M
    J Biol Chem; 2021; 296():100152. PubMed ID: 33288674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLD3 affects axonal spheroids and network defects in Alzheimer's disease.
    Yuan P; Zhang M; Tong L; Morse TM; McDougal RA; Ding H; Chan D; Cai Y; Grutzendler J
    Nature; 2022 Dec; 612(7939):328-337. PubMed ID: 36450991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for phospholipase D3 in myotube formation.
    Osisami M; Ali W; Frohman MA
    PLoS One; 2012; 7(3):e33341. PubMed ID: 22428023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing.
    Gavin AL; Huang D; Huber C; Mårtensson A; Tardif V; Skog PD; Blane TR; Thinnes TC; Osborn K; Chong HS; Kargaran F; Kimm P; Zeitjian A; Sielski RL; Briggs M; Schulz SR; Zarpellon A; Cravatt B; Pang ES; Teijaro J; de la Torre JC; O'Keeffe M; Hochrein H; Damme M; Teyton L; Lawson BR; Nemazee D
    Nat Immunol; 2018 Sep; 19(9):942-953. PubMed ID: 30111894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unconventional Trafficking of Mammalian Phospholipase D3 to Lysosomes.
    Gonzalez AC; Schweizer M; Jagdmann S; Bernreuther C; Reinheckel T; Saftig P; Damme M
    Cell Rep; 2018 Jan; 22(4):1040-1053. PubMed ID: 29386126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLD3 gene variants and Alzheimer's disease.
    Hooli BV; Lill CM; Mullin K; Qiao D; Lange C; Bertram L; Tanzi RE
    Nature; 2015 Apr; 520(7545):E7-8. PubMed ID: 25832413
    [No Abstract]   [Full Text] [Related]  

  • 19. PLD3 in non-familial Alzheimer's disease.
    Heilmann S; Drichel D; Clarimon J; Fernández V; Lacour A; Wagner H; Thelen M; Hernández I; Fortea J; Alegret M; Blesa R; Mauleón A; Roca MR; Kornhuber J; Peters O; Heun R; Frölich L; Hüll M; Heneka MT; Rüther E; Riedel-Heller S; Scherer M; Wiltfang J; Jessen F; Becker T; Tárraga L; Boada M; Maier W; Lleó A; Ruiz A; Nöthen MM; Ramirez A
    Nature; 2015 Apr; 520(7545):E3-5. PubMed ID: 25832411
    [No Abstract]   [Full Text] [Related]  

  • 20. PLD3 and sporadic Alzheimer's disease risk.
    Lambert JC; Grenier-Boley B; Bellenguez C; Pasquier F; Campion D; Dartigues JF; Berr C; Tzourio C; Amouyel P
    Nature; 2015 Apr; 520(7545):E1. PubMed ID: 25832408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.